Literature DB >> 8463608

Dorsal approach to scaphoid nonunion.

H K Watson1, E C Pitts, D Ashmead, M V Makhlouf, J Kauer.   

Abstract

The surgical approach for treatment of scaphoid nonunion usually involves various combinations of screws and Kirschner wires, with or without bone grafts. This article reports our results with 36 dorsal-approach bone grafting procedures for treatment of scaphoid nonunion with Kirschner wires. Union was achieved in 89%. The average follow-up was 5 years. Flexion/extension averaged 76% of the opposite wrist, and grip strength was 88% of the opposite hand. Ninety-one percent of the employed patients returned to their original jobs. The dorsal approach provides satisfactory exposure for fragment reduction and bone grafting.

Entities:  

Mesh:

Year:  1993        PMID: 8463608     DOI: 10.1016/0363-5023(93)90376-e

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  Cancellous bone graft and Kirschner wire fixation as a treatment for cavitary-type scaphoid nonunions exhibiting DISI.

Authors:  Stuart G Kirkham; Michael J Millar
Journal:  Hand (N Y)       Date:  2011-11-17

2.  Scaphoid Nonunion With Poor Prognostic Factors: The Role of the Free Medial Femoral Condyle Vascularized Bone Graft.

Authors:  Tahseen Chaudhry; Lauren Uppal; Dominic Power; Michael Craigen; Simon Tan
Journal:  Hand (N Y)       Date:  2016-08-20

3.  The Vascularity and Osteogenesis of a Vascularized Flap for the Treatment of Scaphoid Nonunion: The Pedicle Volar Distal Radial Periosteal Flap.

Authors:  Cary Tanner; Toby Johnson; Alex Majors; Vincent R Hentz; Lisa Husak; Edward Walker Gallego; Brad Christ; Nathan Hoekzema
Journal:  Hand (N Y)       Date:  2018-01-22

4.  Study of Anatomical Variations of 1,2 Intercompartmental Supraretinacular Artery-Based Vascularized Bone Graft in Cadavers.

Authors:  Vineeth Varma; Vineet Dabas; Saikat Jena; Sumit Sural; Sabita Mishra; Anil K Dhal
Journal:  Indian J Orthop       Date:  2020-05-11       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.